Publications by authors named "Brandon Blue"

Claim this Profile
D
Dermatologic Adverse Effects With Elranatamab Mimicking Talquetamab.
M Bakri Hammami, Sean P Haney, Danny DeAvila, Julia Fadul, Christine E Simonelli, Brandon Blue

Am J Hematol· January 2026

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Post-progression outcomes following BCMA-directed CAR T-cell therapy in myeloma: impact of extramedullary and paramedullary disease.
Ziad Abuhelwa, Fnu Amisha, Wenyi Fan, Gabriel De Avila, Doris K Hansen, Brandon Blue

Front Oncol· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Target antigen and plasma cell phenotype are critical factors for sensitivity to response-adapted daratumumab therapy.
Mark B Meads, Xiaohong Zhao, David R Noyes, Praneeth Sudalagunta, Alexandra Achille, Brandon J Blue

Blood· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cytopenias and infections following ciltacabtagene autoleucel in heavily-pretreated relapsed or refractory multiple myeloma.
Danai Dima, Jennifer M Logue, Syed Hamza Bin Waqar, Lauren C Peres, Christelle M Colin-Leitzinger, Brandon Blue

Haematologica· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Tumor burden quantified by soluble B-cell maturation antigen and metabolic tumor volume determines myeloma CAR-T outcomes.
Ciara L Freeman, Jerald Noble, Meghan Menges, Ricardo Villanueva, Justyn Y Nakashima, Brandon Blue

Blood· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cardiovascular adverse events and outcomes after anti-BCMA CAR-T for relapsed and refractory multiple myeloma.
Stefanie Palfi, Lauren C Peres, Himara Koelmeyer, Melissa Alsina, Rachid C Baz, Brandon J Blue

Blood Cancer J· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Hydrated cable bacteria exhibit protonic conductivity over long distances.
Bradley G Lusk, Sheba Morgan, Shawn P Mulvaney, Brandon Blue, Sam W LaGasse

Proc Natl Acad Sci U S A· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Safety and efficacy of anti-BCMA CAR-T cell therapy in older adults with multiple myeloma: A systematic review and meta-analysis.
Othman Salim Akhtar, Ba Aqeel Sheeba, Farhan Azad, Lauren Alessi, Doris Hansen, Brandon Blue

J Geriatr Oncol· March 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Simple Score of Albumin and CRP Predicts High-Grade Toxicity in Patients with Multiple Myeloma Receiving CAR-T Therapy.
Othman S Akhtar, Karnav Modi, Jongphil Kim, Lawrence Skelson, Eric Smith, Brandon Blue

Transplant Cell Ther· March 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Racial and ethnic differences in clinical outcomes among patients with multiple myeloma treated with CAR T-cell therapy.
Lauren C Peres, Laura B Oswald, Christen M Dillard, Gabriel De Avila, Taiga Nishihori, Brandon J Blue

Blood Adv· January 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Addressing the disparities: the approach to the African American patient with multiple myeloma.
Manisha Bhutani, Brandon J Blue, Craig Cole, Ashraf Z Badros, Saad Z Usmani

Blood Cancer J· December 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Guarding the Heart in an Era of "Tachy-CAR-T": The Rapid Proliferation of a Transformative Therapy.
Brandon Blue, Mohammed Alomar, Frederick L Locke

JACC CardioOncol· December 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Racial and Socioeconomic Disparities in Long-Term Outcomes in ≥1 Year Allogeneic Hematopoietic Cell Transplantation Survivors: A CIBMTR Analysis.
Brandon J Blue, Ruta Brazauskas, Karen Chen, Jinalben Patel, Amer M Zeidan

Transplant Cell Ther· November 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Culturally Responsive Care Delivery in Oncology: The Example of Multiple Myeloma.
Brandon Blue, Amy Pierre, Joseph Mikhael

Clin Lymphoma Myeloma Leuk· September 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Patient-Reported Outcomes among Multiple Myeloma Patients Treated with Standard of Care Idecabtagene Vicleucel.
Laura B Oswald, Lisa M Gudenkauf, Xiaoyin Li, Gabriel De Avila, Lauren C Peres, Brandon Blue

Cancers (Basel)· September 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cardiac events after standard of care idecabtagene vicleucel for relapsed and refractory multiple myeloma.
Dae Hyun Lee, Abhishek Kumar, Turab Mohammed, Lauren C Peres, Melissa Alsina, Brandon J Blue

Blood Adv· August 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Early cytopenias and infections after standard of care idecabtagene vicleucel in relapsed or refractory multiple myeloma.
Jennifer M Logue, Lauren C Peres, Hamza Hashmi, Christelle M Colin-Leitzinger, Alexandria M Shrewsbury, Brandon J Blue

Blood Adv· December 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Adding Cyclophosphamide to Bortezomib and Dexamethasone was not Associated With Improved Outcomes of Patients With Newly Diagnosed Light Chain Amyloidosis: A Retrospective Study.
Yumeng Zhang, Lauren Duncanson, Jason Brayer, Frederic Reu, Doris Hansen, Brandon Blue

Clin Lymphoma Myeloma Leuk· August 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Socioeconomic and Racial Disparity in Chimeric antigen receptor T cell (CART)Therapy Access.
Brandon Blue

Transplant Cell Ther· July 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Racial and ethnic differences in clonal hematopoiesis, tumor markers, and outcomes of patients with multiple myeloma.
Lauren C Peres, Christelle M Colin-Leitzinger, Mingxiang Teng, Julie Dutil, Raghunandan R Alugubelli, Brandon Blue

Blood Adv· June 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Enabling remote quantum emission in 2D semiconductors via porous metallic networks.
Jose J Fonseca, Andrew L Yeats, Brandon Blue, Maxim K Zalalutdinov, Todd Brintlinger

Nat Commun· January 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impact of an Inpatient Palliative Care Consultation in Terminally Ill Cancer Patients.
Brandon Blue, Radhakrishna Vegunta, Miriam Rodin, Setu Patolia, Nishant Poddar

Cureus· July 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Race-based differences in routine cytogenetic profiles of patients with multiple myeloma.
Brandon J Blue, Suhong Luo, Kristen M Sanfilippo, Arun Ganti, Jason Gumbel

Br J Haematol· January 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Statins Are Associated With Reduced Mortality in Multiple Myeloma.
Kristen Marie Sanfilippo, Jesse Keller, Brian F Gage, Suhong Luo, Tzu-Fei Wang, Brandon Blue

J Clin Oncol· November 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis